[go: up one dir, main page]

ATE546544T1 - Verfahren zur diagnose und behandlung von lungenkrebs - Google Patents

Verfahren zur diagnose und behandlung von lungenkrebs

Info

Publication number
ATE546544T1
ATE546544T1 AT99914292T AT99914292T ATE546544T1 AT E546544 T1 ATE546544 T1 AT E546544T1 AT 99914292 T AT99914292 T AT 99914292T AT 99914292 T AT99914292 T AT 99914292T AT E546544 T1 ATE546544 T1 AT E546544T1
Authority
AT
Austria
Prior art keywords
diagnosis
treatment
lung cancer
neoplastic condition
methods
Prior art date
Application number
AT99914292T
Other languages
English (en)
Inventor
Jin Jen
Gary Beaudry
Stephen Madden
Arthur Bertelsen
Original Assignee
Esoterix Genetic Lab Llc
Univ Johns Hopkins
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esoterix Genetic Lab Llc, Univ Johns Hopkins filed Critical Esoterix Genetic Lab Llc
Application granted granted Critical
Publication of ATE546544T1 publication Critical patent/ATE546544T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
AT99914292T 1998-03-31 1999-03-30 Verfahren zur diagnose und behandlung von lungenkrebs ATE546544T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8004498P 1998-03-31 1998-03-31
PCT/US1999/006947 WO1999049774A2 (en) 1998-03-31 1999-03-30 Methods for the diagnosis and treatment of lung cancer

Publications (1)

Publication Number Publication Date
ATE546544T1 true ATE546544T1 (de) 2012-03-15

Family

ID=22154908

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99914292T ATE546544T1 (de) 1998-03-31 1999-03-30 Verfahren zur diagnose und behandlung von lungenkrebs

Country Status (7)

Country Link
US (3) US20070218511A1 (de)
EP (1) EP1095183B1 (de)
JP (3) JP2002509706A (de)
AT (1) ATE546544T1 (de)
AU (1) AU3217599A (de)
CA (2) CA2323058C (de)
WO (1) WO1999049774A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002242552A1 (en) * 2001-03-30 2002-10-15 Dalhousie University Neotic and endoapoptotic cells and detection of neosis and endoapoptosis
US7202045B2 (en) * 2001-09-19 2007-04-10 Regents Of The University Of Michigan Detection and treatment of cancers of the lung
WO2005033285A2 (en) * 2003-09-30 2005-04-14 Sbarro Health Research Organization GENE MODULATION BY RB2/p130 EXPRESSION
JP6702932B2 (ja) * 2017-12-27 2020-06-03 富士フイルム株式会社 細胞撮像制御装置および方法並びにプログラム

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154598B (nl) * 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US3817837A (en) * 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3939350A (en) * 1974-04-29 1976-02-17 Board Of Trustees Of The Leland Stanford Junior University Fluorescent immunoassay employing total reflection for activation
US3996345A (en) * 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4277437A (en) * 1978-04-05 1981-07-07 Syva Company Kit for carrying out chemically induced fluorescence immunoassay
US4275149A (en) * 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4366241A (en) * 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
DE3424893A1 (de) * 1984-07-06 1986-02-06 Agfa-Gevaert Ag, 5090 Leverkusen Photographisches silberhalogenidaufzeichnungsmaterial
US5274087A (en) * 1986-08-13 1993-12-28 Molecular Diagnostics, Inc. cDNA coding for carcinoembryonic antigen (CEA)
US5223482A (en) * 1986-11-17 1993-06-29 Scios Nova Inc. Recombinant Alzheimer's protease inhibitory amyloid protein and method of use
JPH0253486A (ja) * 1988-08-19 1990-02-22 Rikagaku Kenkyusho ヒトｍｙｂ関連遺伝子
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US6040138A (en) 1995-09-15 2000-03-21 Affymetrix, Inc. Expression monitoring by hybridization to high density oligonucleotide arrays
US5464764A (en) 1989-08-22 1995-11-07 University Of Utah Research Foundation Positive-negative selection methods and vectors
US5578444A (en) * 1991-06-27 1996-11-26 Genelabs Technologies, Inc. Sequence-directed DNA-binding molecules compositions and methods
US5412087A (en) 1992-04-24 1995-05-02 Affymax Technologies N.V. Spatially-addressable immobilization of oligonucleotides and other biological polymers on surfaces
US6114114A (en) 1992-07-17 2000-09-05 Incyte Pharmaceuticals, Inc. Comparative gene transcript analysis
WO1994007538A1 (en) * 1992-10-01 1994-04-14 Thomas Jefferson University ANTISENSE OLIGONUCLEOTIDES TO B-m^_y^_b^_ PROTO-ONCOGENE
US5578832A (en) 1994-09-02 1996-11-26 Affymetrix, Inc. Method and apparatus for imaging a sample on a device
US5631734A (en) 1994-02-10 1997-05-20 Affymetrix, Inc. Method and apparatus for detection of fluorescently labeled materials
US5734039A (en) * 1994-09-15 1998-03-31 Thomas Jefferson University Antisense oligonucleotides targeting cooperating oncogenes
US5795716A (en) 1994-10-21 1998-08-18 Chee; Mark S. Computer-aided visualization and analysis system for sequence evaluation
US5695980A (en) * 1995-06-06 1997-12-09 Human Genome Sciences Polynucleotides, vectors, cells and an expression method for human MutT2
CA2178022A1 (en) 1995-06-01 1996-12-02 Michael Hayden Mouse model for huntington's disease and related dna sequences
US5695937A (en) * 1995-09-12 1997-12-09 The Johns Hopkins University School Of Medicine Method for serial analysis of gene expression
US5888796A (en) * 1996-01-31 1999-03-30 St. Louis University Clone of a nucleotide sequence encoding a protein having two functions
US5985567A (en) * 1997-08-15 1999-11-16 Beckman Coulter, Inc. Hybridization detection by pretreating bound single-stranded probes
EP1066311A4 (de) * 1998-03-31 2002-04-10 Genzyme Corp Zusammensetzungen und methoden zur identifizierung von lungentumorzellen
US20040166527A1 (en) * 1999-03-30 2004-08-26 Beaudry Gary A. Compositions and methods for the identification of lung tumor cells
WO2005033285A2 (en) * 2003-09-30 2005-04-14 Sbarro Health Research Organization GENE MODULATION BY RB2/p130 EXPRESSION

Also Published As

Publication number Publication date
EP1095183A2 (de) 2001-05-02
EP1095183B1 (de) 2012-02-22
CA2323058C (en) 2011-03-29
US20100062443A1 (en) 2010-03-11
CA2735260A1 (en) 1999-10-07
CA2323058A1 (en) 1999-10-07
US7846667B2 (en) 2010-12-07
JP2009171985A (ja) 2009-08-06
JP2012147796A (ja) 2012-08-09
US20110091892A1 (en) 2011-04-21
WO1999049774A9 (en) 2000-02-24
JP2002509706A (ja) 2002-04-02
EP1095183A4 (de) 2004-09-15
WO1999049774A3 (en) 1999-12-29
US8067240B2 (en) 2011-11-29
AU3217599A (en) 1999-10-18
US20070218511A1 (en) 2007-09-20
WO1999049774A2 (en) 1999-10-07

Similar Documents

Publication Publication Date Title
DE69720058D1 (de) Vorrichtung für diagnose und behandlung von arrhytmien
DE69726195D1 (de) Vorrichtung für diagnose und behandlung von arrhytmien
DE60108230D1 (de) Vorrichtung für diagnose und behandlung von arrhytmien
DE69626227D1 (de) Hierarchisches regelbasiertes system zur diagnose und behandlung von arrythmien
EP0953153A4 (de) Verfahren zur diagnose und behandlung von gliomas
EP1075535A4 (de) Verfahren zur diagnose und behandlung von chronischem beckenschmerz
NO20016427D0 (no) Blandinger og fremgangsmåter for behandling av diagnose av lungekreft
DE60329165D1 (de) Detektion und/oder beobachtung von synuclein-assoziierten krankheiten
DE69633717D1 (de) Monoklonale anti-cd6 antikörper zur behandlung und diagnose von psoriasis
DE69939269D1 (de) Verfahren zur bestimmung der suzeptibilität zur sepsisentwicklung und arzneimittel zur behandlung von sepsis
NO994932D0 (no) Blandinger og fremgangsmaater for behandling og diagnose av brystkreft
DE69718018D1 (de) Materialien und methoden zur diagnose und behandlung von diabetes und fettleibigkeit
ATE241141T1 (de) Behandlung und diagnose helicobacter pylori infektionen
ATE181422T1 (de) Verfahren zur diagnose von praeklampsie
EP1109929A4 (de) Verfahren zur diagnose von magensalz-schwundsyndrom und alzheimerscher krankheit und behandlungsverfahren
ATE338142T1 (de) Methoden zur diagnose und behandlung von herzkrankheiten
ATE546544T1 (de) Verfahren zur diagnose und behandlung von lungenkrebs
ATE213163T1 (de) Verfahren zur behandlung von motorischen defiziten
DE59704432D1 (de) Vorrichtung zur endoskopischen Diagnose und Behandlung von Gewebe
DE60144493D1 (de) Verfahren zur bestimmung und behandlung von tuberöse-sklerose komplex assoziierten erkrankungen
DE60226324D1 (de) Glykopeptide, deren herstellung und verwendung in der diagnose oder behandlung von multipler sklerose
DE69938729D1 (de) Verfahren zur diagnose von knochenmetastasen aus malignen tumoren
DE60134158D1 (de) Zusammensetzungen und verfahren für therapie und diagnose von lungenkrebs
EP0981357A4 (de) Verfahren und zusammensetzungen zur diagnose und behandlung von neuropsychiatrischen erkrankungen
EP1371729A3 (de) Verwendungen von TFF3 bindenden Substanzen zur Diagnose und Behandlung von Krebserkrankungen